Atm heterozygosity does not increase tumor susceptibility to ionizing radiation alone or in a p53 heterozygous background
Ataxia-Telangiectasia (A-T) is an autosomal recessive human disease characterized by genetic instability, radiosensitivity, immunodeficiency and cancer predisposition, because of mutation in both alleles of the ATM (ataxia-telangiectasia mutated) gene. The role of Atm heterozygosity in cancer suscep...
Saved in:
| Published in: | Oncogene Vol. 27; no. 51; pp. 6596 - 6600 |
|---|---|
| Main Authors: | , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
London
Nature Publishing Group UK
30.10.2008
Nature Publishing Group |
| Subjects: | |
| ISSN: | 0950-9232, 1476-5594, 1476-5594 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Ataxia-Telangiectasia (A-T) is an autosomal recessive human disease characterized by genetic instability, radiosensitivity, immunodeficiency and cancer predisposition, because of mutation in both alleles of the
ATM
(ataxia-telangiectasia mutated) gene. The role of
Atm
heterozygosity in cancer susceptibility is controversial, in both human and mouse. Earlier studies identified deletions near the
Atm
gene on mouse chromosome 9 in radiation-induced lymphomas from p53 heterozygous mice. To determine whether
Atm
was the target of these deletions,
Atm
heterozygous as well as
Atm/P53
double heterozygous mice were treated with ionizing radiation. There were no significant differences in tumor latency, progression and lifespan after γ-radiation in
Atm
heterozygous mice compared with their wild-type control counterparts. Deletions were found on chromosome 9 near the
Atm
locus in radiation-induced tumors, but in 50% of the cases the deletion included the knockout allele, and the expression of
Atm
was maintained in the tumors indicating that loss of heterozygosity on chromosome 9 is not driven by
Atm
, but by an alternative tumor suppressor gene located near
Atm
on this chromosome. We conclude that
Atm
heterozygosity does not confer an increase in tumor susceptibility in this context. |
|---|---|
| Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ISSN: | 0950-9232 1476-5594 1476-5594 |
| DOI: | 10.1038/onc.2008.280 |